Mycobacterium bolletii respiratory infections.
Contrary to other species in the Mycobacterium chelonae-abscessus complex, we reidentified M. bolletii strains isolated from 4 respiratory patients and found these strains to be uniformly resistant to clarithromycin. No mutations previously associated with macrolide resistance in bacteria were detected in either the 23S rDNA or the genes encoding riboproteins L4 and L22.
Adékambi
Toïdi
T
Université de la Méditerranée, Marseille, France.
Drancourt
Michel
M
D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000995:Antitubercular Agents / Q000494:pharmacology / Q000627:therapeutic use; D004269:DNA, Bacterial / Q000032:analysis; D004275:DNA, Ribosomal; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009161:Mycobacterium / Q000145:classification / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D009164:Mycobacterium Infections / Q000188:drug therapy / Q000382:microbiology*; D012338:RNA, Ribosomal, 23S / Q000235:genetics; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000382:microbiology*; D017422:Sequence Analysis, DNA; D013183:Sputum / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D004269:DNA, Bacterial; D004275:DNA, Ribosomal; D012338:RNA, Ribosomal, 23S